Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the FoF Domestic median (151 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 28 Oct 2024 – 20 Aug 2026, limited by Mirae Asset Gold ETF Fund of Fund. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | Mirae Asset Gold ETF Fund of Fund | Gold |
|---|---|---|
| 28 Oct 2024 | ₹100.00 | ₹100.00 |
| 22 Dec 2024 | ₹96.79 | ₹96.26 |
| 15 Feb 2025 | ₹110.04 | ₹109.79 |
| 11 Apr 2025 | ₹118.18 | ₹118.43 |
| 05 Jun 2025 | ₹124.19 | ₹124.25 |
| 30 Jul 2025 | ₹125.69 | ₹125.25 |
| 24 Sep 2025 | ₹144.05 | ₹143.87 |
| 18 Nov 2025 | ₹153.59 | ₹153.41 |
| 12 Jan 2026 | ₹176.88 | ₹177.50 |
| 08 Mar 2026 | ₹198.37 | ₹198.88 |
| 02 May 2026 | ₹187.05 | ₹187.64 |
| 26 Jun 2026 | ₹174.51 | ₹174.76 |
| 20 Aug 2026 | ₹195.48 | ₹195.93 |
| Metric | Mirae Asset · Direct NAV ₹19.62 High risk ★★★★☆ 1Y | Category median FoF Domestic · 151 funds |
|---|---|---|
| +56.61% | +8.79% | |
| — | +14.76% | |
| — | +11.89% | |
| — | +12.34% | |
| +44.83% | +11.30% | |
| +43.66% | — | |
| — | +13.06% | |
| — | +10.96% | |
| — | +10.76% | |
| Risk | ||
| 24.65% | 15.95% | |
| 2.03 | 0.81 | |
| 2.89 | 1.14 | |
| -23.78% | -19.45% | |
| Gold | — | |
| — | +1.81% | |
| — | 0.94 | |
| — | 98.0% | |
| — | 93.1% | |
| 0.10% | 0.17% | |
| ₹523.19Cr | ₹228.08Cr | |
| 0.05% | — | |
| None | — | |
| ₹99 | — | |
| ₹5.00K | — | |
| — | 11% | |
| Ritesh Patel · 1.8y | — | |
| 28 Oct 2024 | — | |
| — | — | |
| — | — | |
| -0.1% | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.